Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology
Nov 14, 2017 12:01 pm UTC| Business
CLARKSVILLE, Md., Nov. 14, 2017 -- Neuronascent, Inc. (www.neuronascent.com), a biopharmaceutical company focused on oral therapeutics to promote neuron regeneration, today announced the European Patent Office has...
UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments
Nov 14, 2017 12:01 pm UTC| Business
RA’ANANA, Israel and NEW YORK, Nov. 14, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on...
Nov 14, 2017 12:00 pm UTC| Business
– Up to $1.55B in Upfront, Regulatory, and Commercial Milestones – – Loxo Oncology and Bayer to Co-Promote in U.S. with a 50/50 Profit Share; Bayer to Commercialize ROW – – Loxo Oncology to Lead Global Development...
21Vianet Group, Inc. to Announce Third Quarter 2017 Financial Results
Nov 14, 2017 12:00 pm UTC| Business
BEIJING, Nov. 14, 2017 -- 21Vianet Group, Inc. (Nasdaq:VNET) (“21Vianet” or the “Company”), a leading carrier-neutral Internet data center services provider in China, today announced that it plans to release its third...
VBL Therapeutics Announces Third Quarter 2017 Financial Results
Nov 14, 2017 12:00 pm UTC| Business
Conference Call and Webcast at 8:30am Eastern Time Today TEL AVIV, Israel, Nov. 14, 2017 -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and...
FLX Merchandise from Farelogix Helps Airlines Take Control of its Offer
Nov 14, 2017 12:00 pm UTC| Business
MIAMI, Nov. 14, 2017 -- Farelogix today announced that Alaska Airlines has gone into production with FLX Merchandise, the industry’s leading enterprise merchandising and rules engine. Alaska Airlines is using FLX...
FactSet Announces Chief Technology and Product Officer
Nov 14, 2017 12:00 pm UTC| Business
NORWALK, Conn., Nov. 14, 2017 -- FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading services, today announced that Gene Fernandez will...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update